Non-Medical Switching from Tocilizumab to Sarilumab in Rheumatoid Arthritis Patients with Low Disease Activity, an Observational Study

den Broeder, N; den Broeder, AA; Verhoef, LM; van den Hoogen, FHJ; van der Maas, A; van den Bemt, BJF

den Broeder, N (通讯作者),Sint Maartensklin, Dept Rheumatol, Nijmegen, Netherlands.;den Broeder, N (通讯作者),Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands.

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023; 114 (4): 810

Abstract

Tocilizumab and sarilumab are IL-6-receptor antagonists registered for rheumatoid arthritis (RA), with equal effectiveness and safety. Switching from ......

Full Text Link